ArticleArthritis research & therapy2022

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study.

John K Botson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.